FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / BMC Vet Res / Effect of a GLP-1 mimetic on the insulin response to oral su...
BMC veterinary research2022; 18(1); 294; doi: 10.1186/s12917-022-03394-2

Effect of a GLP-1 mimetic on the insulin response to oral sugar testing in horses.

Abstract: Insulin dysregulation (ID) is the most important risk factor for the development of laminitis in horses and therapies to control it are needed. Objective: To assess the effects of a single dose of the synthetic GLP-1 analog exenatide on postprandial insulin dynamics. We hypothesized that exenatide would improve insulin sensitivity and lower postprandial blood insulin concentrations. Methods: Randomized, crossover, experimental study. Methods: Six horses (3 mares, 3 geldings; 2 with normal insulin regulation [NIR] and 4 with mild ID). Methods: Horses completed both study arms: subcutaneous administration of exenatide (or no treatment) 30 min before an oral sugar test (0.15 ml/kg of Karo Syrup). Blood samples obtained over 240 min were assayed for glucose, insulin, lactate, c-peptide and total GLP-1. The area under the curve (AUC) was calculated using the trapezoidal rule. Insulin sensitivity (S) was estimated using a mathematical model. Results: Exenatide resulted in a postprandial decrease of 20% (effect size: 2673 µU·min/ml; 95% CI: 900 - 4446 µU·min/ml; P = 0.003) in AUC of plasma insulin (control; mean AUC insulin: 11,989 µU·min/ml; 95% CI: 9673 - 14,305 µU·min/ml, exenatide; mean AUC insulin: 9316 µU·min/ml; 95% CI: 7430 - 11,202 µU·min/ml). Exenatide resulted in an approximately threefold increase (effect size: 5.56 10· µU/ml·min; 95% CI: 0.95 - 10.1 10· µU/ml·min; P = 0.02) in estimated insulin sensitivity (control mean S: 1.93 10· µU/ml·min; 95% CI: 0.005 - 3.86 10·µU/ml·min vs. exenatide mean S: 7.49 10· µU/ml·min; 95% CI: 3.46 - 11.52 10· µU/ml·min). Conclusions: The decrease in insulin response to carbohydrates was due to an increase in whole-body insulin sensitivity. GLP-1 agonists may have therapeutic potential for ID in horses.
© 2022. The Author(s).
Get Full Text
Publication Date: 2022-07-29 PubMed ID: 35906619PubMed Central: PMC9336084DOI: 10.1186/s12917-022-03394-2Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article
  • Randomized Controlled Trial
  • Veterinary

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research article examines the effects of a synthetic GLP-1 analog, exenatide, on insulin regulation in horses, particularly with its potential to enhance insulin sensitivity and lower blood insulin concentrations post eating, hence suggesting its potential use as a therapeutic intervention for insulin dysregulation in horses.

Research Objectives and Hypothesis

  • The primary objective of the research was to assess the influence of a single dose of exenatide, a synthetic GLP-1 analog, on postprandial insulin dynamics in horses.
  • The researchers hypothesised that administration of exenatide would enhance insulin sensitivity and cause a decrease in postprandial blood insulin concentrations in horses.

Methods and Procedures

  • The investigation was undertaken as a randomized, crossover, experimental study involving six horses (3 mares, 3 geldings).
  • The horses, of which two had normal insulin regulation (NIR) and four had mild insulin dysregulation (ID), were subjected to both study arms – subcutaneous application of exenatide (or no treatment) thirty minutes prior to an oral sugar test.
  • The sugar test involved administering 0.15 ml/kg of Karo Syrup and subsequently obtaining blood samples over a period of 240 minutes.
  • The blood samples were tested for glucose, insulin, lactate, c-peptide, and total GLP-1 levels, and the area under the curve (AUC) for these values were calculated using the trapezoidal rule.
  • Insulin sensitivity was then estimated using a mathematical model.

Results

  • The use of exenatide resulted in a 20% decrease in the postprandial AUC of plasma insulin, confirming the lowered blood insulin concentration post eating.
  • Interestingly, the administered exenatide resulted in an approximately threefold increase in estimated insulin sensitivity, validating the hypothesis of the study.

Conclusion

  • The decrease in carbohydrate-induced insulin response was found to be due to an increase in whole-body insulin sensitivity due to exenatide administration.
  • The findings of the research suggests the potential of GLP-1 agonists, such as the tested exenatide, as therapeutic solutions for managing ID in horses.

Cite This Article

APA
Stefanovski D, Robinson MA, Van Eps A. (2022). Effect of a GLP-1 mimetic on the insulin response to oral sugar testing in horses. BMC Vet Res, 18(1), 294. https://doi.org/10.1186/s12917-022-03394-2

Publication

BMC veterinary research
ISSN: 1746-6148
NlmUniqueID: 101249759
Country: England
Language: English
Volume: 18
Issue: 1
Pages: 294
PII: 294

Researcher Affiliations

Stefanovski, Darko
  • Department of Clinical Studies, School of Veterinary Medicine, University of Pennsylvania, New Bolton Center Campus, 382 West Street Road, Kennett Square, PA, 19348, USA. sdarko@upenn.edu.
Robinson, Mary A
  • Department of Clinical Studies, School of Veterinary Medicine, University of Pennsylvania, New Bolton Center Campus, 382 West Street Road, Kennett Square, PA, 19348, USA.
  • PA Equine Toxicology & Research Laboratory, 220 East Rosedale Avenue, West Chester, PA, 19382, USA.
Van Eps, Andrew
  • Department of Clinical Studies, School of Veterinary Medicine, University of Pennsylvania, New Bolton Center Campus, 382 West Street Road, Kennett Square, PA, 19348, USA.

MeSH Terms

  • Animals
  • Blood Glucose
  • Exenatide
  • Female
  • Glucagon-Like Peptide 1
  • Horse Diseases
  • Horses
  • Insulin
  • Insulin Resistance
  • Male
  • Sugars

Grant Funding

  • PENUSDADSFo0 / U.S. Department of Agriculture
  • PENUSDADSFo0 / U.S. Department of Agriculture

Conflict of Interest Statement

The authors declare no competing interests. The authors have no competing interests to report. All experimental protocols have been approved by Institutional Animal Care and Use Committee.

References

This article includes 43 references
  1. McGowan CM. Endocrinopathic laminitis.. Vet Clin North Am Equine Pract 2010 Aug;26(2):233-7.
    doi: 10.1016/j.cveq.2010.04.009pubmed: 20699171google scholar: lookup
  2. Asplin KE, Sillence MN, Pollitt CC, McGowan CM. Induction of laminitis by prolonged hyperinsulinaemia in clinically normal ponies.. Vet J 2007 Nov;174(3):530-5.
    doi: 10.1016/j.tvjl.2007.07.003pubmed: 17719811google scholar: lookup
  3. de Laat MA, McGowan CM, Sillence MN, Pollitt CC. Equine laminitis: induced by 48 h hyperinsulinaemia in Standardbred horses.. Equine Vet J 2010 Mar;42(2):129-35.
    doi: 10.2746/042516409X475779pubmed: 20156248google scholar: lookup
  4. de Laat MA, Pollitt CC, Kyaw-Tanner MT, McGowan CM, Sillence MN. A potential role for lamellar insulin-like growth factor-1 receptor in the pathogenesis of hyperinsulinaemic laminitis.. Vet J 2013 Aug;197(2):302-6.
    doi: 10.1016/j.tvjl.2012.12.026pubmed: 23394844google scholar: lookup
  5. Fitzgerald DM, Walsh DM, Sillence MN, Pollitt CC, de Laat MA. Insulin and incretin responses to grazing in insulin-dysregulated and healthy ponies.. J Vet Intern Med 2019 Jan;33(1):225-232.
    doi: 10.1111/jvim.15363pmc: PMC6335545pubmed: 30506731google scholar: lookup
  6. Chameroy KA, Frank N, Elliott SB, Boston RC. Comparison of plasma active glucagon-like peptide 1 concentrations in normal horses and those with equine metabolic syndrome and in horses placed on a high-grain diet.. J Equine Vet 2016;40:16–25.
    doi: 10.1016/j.jevs.2016.01.009google scholar: lookup
  7. de Laat MA, McGree JM, Sillence MN. Equine hyperinsulinemia: investigation of the enteroinsular axis during insulin dysregulation.. Am J Physiol Endocrinol Metab 2016 Jan 1;310(1):E61-72.
    doi: 10.1152/ajpendo.00362.2015pubmed: 26530154google scholar: lookup
  8. Bamford NJ, Baskerville CL, Harris PA, Bailey SR. Postprandial glucose, insulin, and glucagon-like peptide-1 responses of different equine breeds adapted to meals containing micronized maize.. J Anim Sci 2015 Jul;93(7):3377-83.
    doi: 10.2527/jas.2014-8736pubmed: 26440006google scholar: lookup
  9. Alexiadou K, Anyiam O, Tan T. Cracking the combination: Gut hormones for the treatment of obesity and diabetes.. J Neuroendocrinol 2019 May;31(5):e12664.
    pmc: PMC6563152pubmed: 30466162doi: 10.1111/jne.12664google scholar: lookup
  10. Ionut V, Liberty IF, Hucking K, Lottati M, Stefanovski D, Zheng D, Bergman RN. Exogenously imposed postprandial-like rises in systemic glucose and GLP-1 do not produce an incretin effect, suggesting an indirect mechanism of GLP-1 action.. Am J Physiol Endocrinol Metab 2006 Oct;291(4):E779-85.
    doi: 10.1152/ajpendo.00106.2005pubmed: 16720628google scholar: lookup
  11. Zheng D, Ionut V, Mooradian V, Stefanovski D, Bergman RN. Exenatide sensitizes insulin-mediated whole-body glucose disposal and promotes uptake of exogenous glucose by the liver.. Diabetes 2009 Feb;58(2):352-9.
    doi: 10.2337/db08-0875pmc: PMC2628608pubmed: 19011168google scholar: lookup
  12. Cornell S. A review of GLP-1 receptor agonists in type 2 diabetes: A focus on the mechanism of action of once-weekly agents.. J Clin Pharm Ther 2020 Sep;45 Suppl 1(Suppl 1):17-27.
    doi: 10.1111/jcpt.13230pmc: PMC7540167pubmed: 32910490google scholar: lookup
  13. Aaseth J, Ellefsen S, Alehagen U, Sundfør TM, Alexander J. Diets and drugs for weight loss and health in obesity - An update.. Biomed Pharmacother 2021 Aug;140:111789.
    doi: 10.1016/j.biopha.2021.111789pubmed: 34082399google scholar: lookup
  14. Kheder MH, Bailey SR, Dudley KJ, Sillence MN, de Laat MA. Equine glucagon-like peptide-1 receptor physiology.. PeerJ 2018;6:e4316.
    doi: 10.7717/peerj.4316pmc: PMC5793710pubmed: 29404215google scholar: lookup
  15. Restifo MM, Frank N, Hermida P, Sanchez-Londoño A. Effects of withholding feed on thyrotropin-releasing hormone stimulation test results and effects of combined testing on oral sugar test and thyrotropin-releasing hormone stimulation test results in horses.. Am J Vet Res 2016 Jul;77(7):738-48.
    doi: 10.2460/ajvr.77.7.738pubmed: 27347827google scholar: lookup
  16. Knowles EJ, Harris PA, Elliott J, Menzies-Gow NJ. Use of the oral sugar test in ponies when performed with or without prior fasting.. Equine Vet J 2017 Jul;49(4):519-524.
    doi: 10.1111/evj.12607pubmed: 27381044google scholar: lookup
  17. Schuver A, Frank N, Chameroy KA, Elliott SB. Assessment of insulin and glucose dynamics by using an oral sugar test in horses.. J Equine Vet 2014;34:465–470.
    doi: 10.1016/j.jevs.2013.09.006google scholar: lookup
  18. Nauck MA, Holst JJ, Willms B, Schmiegel W. Glucagon-like peptide 1 (GLP-1) as a new therapeutic approach for type 2-diabetes.. Exp Clin Endocrinol Diabetes 1997;105(4):187-95.
    doi: 10.1055/s-0029-1211750pubmed: 9285204google scholar: lookup
  19. Nauck MA, Meier JJ. Incretin hormones: Their role in health and disease.. Diabetes Obes Metab 2018 Feb;20 Suppl 1:5-21.
    doi: 10.1111/dom.13129pubmed: 29364588google scholar: lookup
  20. Bergman RN, Yang YJ, Hope ID, Ader M. The role of the transcapillary insulin transport in the efficiency of insulin action: studies with glucose clamps and the minimal model.. Horm Metab Res Suppl 1990;24:49-56.
    pubmed: 2272626
  21. Chai W, Fu Z, Aylor KW, Barrett EJ, Liu Z. Liraglutide prevents microvascular insulin resistance and preserves muscle capillary density in high-fat diet-fed rats.. Am J Physiol Endocrinol Metab 2016 Sep 1;311(3):E640-8.
    doi: 10.1152/ajpendo.00205.2016pmc: PMC5142002pubmed: 27436611google scholar: lookup
  22. Li Z, Zhu Y, Li C, Tang Y, Jiang Z, Yang M, Ni CL, Li D, Chen L, Niu W. Liraglutide ameliorates palmitate-induced insulin resistance through inhibiting the IRS-1 serine phosphorylation in mouse skeletal muscle cells.. J Endocrinol Invest 2018 Sep;41(9):1097-1102.
    doi: 10.1007/s40618-018-0836-xpubmed: 29374854google scholar: lookup
  23. Campioni M, Toffolo G, Basu R, Rizza RA, Cobelli C. Minimal model assessment of hepatic insulin extraction during an oral test from standard insulin kinetic parameters.. Am J Physiol Endocrinol Metab 2009 Oct;297(4):E941-8.
    doi: 10.1152/ajpendo.90842.2008pmc: PMC2763784pubmed: 19671837google scholar: lookup
  24. Edgerton DS, Kraft G, Smith M, Farmer B, Williams PE, Coate KC, Printz RL, O'Brien RM, Cherrington AD. Insulin's direct hepatic effect explains the inhibition of glucose production caused by insulin secretion.. JCI Insight 2017 Mar 23;2(6):e91863.
    doi: 10.1172/jci.insight.91863pmc: PMC5358484pubmed: 28352665google scholar: lookup
  25. Zheng D, Ionut V, Mooradian V, Stefanovski D, Bergman RN. Exenatide sensitizes insulin-mediated whole-body glucose disposal and promotes uptake of exogenous glucose by the liver.. Diabetes 2009 Feb;58(2):352-9.
    pmc: PMC2628608pubmed: 19011168doi: 10.2337/db08-0875google scholar: lookup
  26. Acosta A, Camilleri M, Burton D, O'Neill J, Eckert D, Carlson P, Zinsmeister AR. Exenatide in obesity with accelerated gastric emptying: a randomized, pharmacodynamics study.. Physiol Rep 2015 Nov;3(11).
    doi: 10.14814/phy2.12610pmc: PMC4632965pubmed: 26542264google scholar: lookup
  27. Kilberg MJ, Harris C, Sheikh S, Stefanovski D, Cuchel M, Kubrak C, Hadjiliadis D, Rubenstein RC, Rickels MR, Kelly A. Hypoglycemia and Islet Dysfunction Following Oral Glucose Tolerance Testing in Pancreatic-Insufficient Cystic Fibrosis.. J Clin Endocrinol Metab 2020 Oct 1;105(10):3179-89.
    doi: 10.1210/clinem/dgaa448pmc: PMC7755140pubmed: 32668452google scholar: lookup
  28. Ruetten H, Gebauer M, Raymond RH, Calle RA, Cobelli C, Ghosh A, Robertson RP, Shankar SS, Staten MA, Stefanovski D, Vella A, Wright K, Fryburg DA. Mixed Meal and Intravenous L-Arginine Tests Both Stimulate Incretin Release Across Glucose Tolerance in Man: Lack of Correlation with β Cell Function.. Metab Syndr Relat Disord 2018 Oct;16(8):406-415.
    doi: 10.1089/met.2018.0022pmc: PMC6167614pubmed: 30117761google scholar: lookup
  29. Frank N, Walsh DM. Repeatability of Oral Sugar Test Results, Glucagon-Like Peptide-1 Measurements, and Serum High-Molecular-Weight Adiponectin Concentrations in Horses.. J Vet Intern Med 2017 Jul;31(4):1178-1187.
    doi: 10.1111/jvim.14725pmc: PMC5508339pubmed: 28543933google scholar: lookup
  30. Albarazanji K, Nawrocki AR, Gao B, Wang X, Wang YJ, Xiao YF. Effects of mixed meal tolerance test on gastric emptying, glucose and lipid homeostasis in obese nonhuman primates.. Sci Rep 2021 Jun 4;11(1):11866.
    doi: 10.1038/s41598-021-91027-3pmc: PMC8178340pubmed: 34088949google scholar: lookup
  31. Holst JJ. The physiology of glucagon-like peptide 1.. Physiol Rev 2007 Oct;87(4):1409-39.
    doi: 10.1152/physrev.00034.2006pubmed: 17928588google scholar: lookup
  32. Byetta (exenatide) injection. https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021773s9s11s18s22s25lbl.pdf.
  33. Ionut V, Zheng D, Stefanovski D, Bergman RN. Exenatide can reduce glucose independent of islet hormones or gastric emptying.. Am J Physiol Endocrinol Metab 2008 Aug;295(2):E269-77.
    doi: 10.1152/ajpendo.90222.2008pmc: PMC2519754pubmed: 18492781google scholar: lookup
  34. Hoffman RM, Boston RC, Stefanovski D, Kronfeld DS, Harris PA. Obesity and diet affect glucose dynamics and insulin sensitivity in Thoroughbred geldings.. J Anim Sci 2003 Sep;81(9):2333-42.
    doi: 10.2527/2003.8192333xpubmed: 12968709google scholar: lookup
  35. Cobelli C, Dalla Man C, Toffolo G, Basu R, Vella A, Rizza R. The oral minimal model method.. Diabetes 2014 Apr;63(4):1203-13.
    doi: 10.2337/db13-1198pmc: PMC4179313pubmed: 24651807google scholar: lookup
  36. Brar PC, Koren D, Gallagher PR, Pendurthi B, Katz LE. Comparison of oral and intravenous glucose tolerance test derived sensitivity and secretory indices in obese adolescents.. Clin Pediatr (Phila) 2013 Mar;52(3):247-53.
    doi: 10.1177/0009922812472251pubmed: 23418053google scholar: lookup
  37. Hodge E, Kowalski A, Torcivia C, Lindborg S, Stefanovski D, Hart K, Frank N, van Eps A. Effect of thyrotropin-releasing hormone stimulation testing on the oral sugar test in horses when performed as a combined protocol.. J Vet Intern Med 2019 Sep;33(5):2272-2279.
    doi: 10.1111/jvim.15601pmc: PMC6766522pubmed: 31432575google scholar: lookup
  38. Tóth F, Frank N, Martin-Jiménez T, Elliott SB, Geor RJ, Boston RC. Measurement of C-peptide concentrations and responses to somatostatin, glucose infusion, and insulin resistance in horses.. Equine Vet J 2010 Mar;42(2):149-55.
    doi: 10.2746/042516409X478497pubmed: 20156251google scholar: lookup
  39. Rings LM, Swink JM, Dunbar LK, Burns TA, Toribio RE. Enteroinsular axis response to carbohydrates and fasting in healthy newborn foals.. J Vet Intern Med 2019 Nov;33(6):2752-2764.
    doi: 10.1111/jvim.15641pmc: PMC6872622pubmed: 31664736google scholar: lookup
  40. Dalla Man C, Caumo A, Cobelli C. The oral glucose minimal model: estimation of insulin sensitivity from a meal test.. IEEE Trans Biomed Eng 2002 May;49(5):419-29.
    doi: 10.1109/10.995680pubmed: 12002173google scholar: lookup
  41. Bergman RN, Ider YZ, Bowden CR, Cobelli C. Quantitative estimation of insulin sensitivity.. Am J Physiol 1979 Jun;236(6):E667-77.
    pubmed: 443421doi: 10.1152/ajpendo.1979.236.6.e667google scholar: lookup
  42. Caumo A, Bergman RN, Cobelli C. Insulin sensitivity from meal tolerance tests in normal subjects: a minimal model index.. J Clin Endocrinol Metab 2000 Nov;85(11):4396-402.
    doi: 10.1210/jcem.85.11.6982pubmed: 11095485google scholar: lookup
  43. Frank N. Equine metabolic syndrome.. Vet Clin North Am Equine Pract 2011 Apr;27(1):73-92.
    doi: 10.1016/j.cveq.2010.12.004pubmed: 21392655google scholar: lookup

Citations

This article has been cited 0 times.
Subscribe to our newsletter
Join 99,344 horse owners like you who receive our email updates on horse health and nutrition.